Helping You Build Wealth With Honest Research
Since 1996. Read On...

The Best Asset Allocation for Your Equity Portfolio

NGL FINE CHM Gains 8%; BSE HEALTHCARE Index Down 0.0%
Thu, 3 Sep 13:53

NGL FINE CHM Gains 8%; BSE HEALTHCARE Index Down 0.0%Image source: Eoneren/www.istockphoto.com

NGL FINE CHM share price has zoomed 8% and is presently trading at Rs 2,898.0.

Meanwhile, the BSE HEALTHCARE index is at 51,243.9 .

Among the top gainers in the BSE HEALTHCARE index today are GRANULES INDIA (up 4.1%) and CAPLIN POINT (up 3.8%).

J.B.Chemicals (down 3.7%) and POLY MEDICURE (down 1.7%) are among the top losers today.

Over the last one year, NGL FINE CHM has moved up from Rs 1,451.0 to Rs 2,898.0, registering a gain of Rs 1,447.0 (up 99.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 43,726.7 to 51,243.9, registering a gain of 17.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were LAURUS LABS (up 117.9%), GRANULES INDIA (up 70.5%) and Aurobindo Pharma (up 62.4%).

Festive Deal: You Get Our Large Cap & Small Cap Research at Just Rs 2,950 + GST.

What About the Benchmark Indices?

The BSE Sensex is at 76,569.9 .

The top losers among the BSE Sensex today are Titan (down 1.9%) and Tech Mahindra (down 1.2%). The most traded stocks in the BSE Sensex are NTPC and HDFC Bank.

In the meantime, NSE Nifty is at 23,912.6 . Titan and Bajaj Auto are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved down from 80,157.9 to 76,569.9, registering a loss of 3,588.0 points (down 4.5%).

NGL FINE CHM Financial Update...

NGL FINE CHM net profit grew 99.1% YoY to Rs 184 million for the quarter ended June 2026, compared to a profit of Rs 92 million a year ago. Net sales rose 33.6% to Rs 1,392 million during the period as against Rs 1,042 million in April-June 2025.

For the year ended March 2026, NGL FINE CHM reported 127.8% increase in net profit to Rs 481 million compared to net profit of Rs 211 million during FY25. Revenue of the company grew 36.0% to Rs 5,010 million during FY26.

The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 31.3.


Equitymaster requests your view! Post a comment on "NGL FINE CHM Gains 8%; BSE HEALTHCARE Index Down 0.0%". Click here!